Lung Cancer
Conference Coverage
Glimmer of promise for nivolumab in neoadjuvant NSCLC therapy
COPENHAGEN – Checkpoint inhibitors have shown good efficacy for treatment of advanced NSCLC, but use in the neoadjuvant setting is still...
Best Practices
Is It All in the Eye of the Beholder? Comparing Pulmonologists’ and Radiologists’ Performance
Experienced pulmonologists and radiologists were equally accurate in diagnosing malignant lung nodules and lung masses seen on low-dose computed...
Original Research
Metastatic Small Cell Carcinoma of the Lung: An Unusual Cause of Acute Fulminant Hepatic Failure
For patients with acute fulminant liver failure, imaging and histopathologic studies are indicated to reveal the underlying etiology, and...
Clinical Review
An Unusual Cause of Shortness of Breath: Primary Tracheal Basal Cell Adenocarcinoma
A rare case of basal cell adenocarcinoma of the salivary gland tissue in the trachea can be difficult to differentiate from basal cell...
Article
Long-Term Survival of a Patient With Late-Stage Non-Small Cell Lung Cancer
Clinical Review
Long-Term Survival of a Patient With Late-Stage Non-Small Cell Lung Cancer
After not responding to chemotherapy and monoclonal antibody therapy, a patient with late-stage non-small cell lung cancer benefited from...
News
Pembrolizumab paired with immunostimulator is safe and tolerable
Combining an immunostimulator with pembrolizumab had good tolerability and safety, in a small phase Ib study.
News
ELCC: Survey reveals worldwide underuse of EGFR-mutation testing
Key clinical point: A significant minority of advanced lung cancer patients worldwide fail to receive initial treatment guided by EGFR-mutation...